Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China flag China · Delayed Price · Currency is CNY
19.15
+0.75 (4.08%)
At close: Mar 6, 2026

SHA:688670 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-93.5-70.9941.5482.46
Depreciation & Amortization
28.8229.8729.7628.08
Other Amortization
1.61.381.381.13
Loss (Gain) From Sale of Assets
0.1--0.230.05
Asset Writedown & Restructuring Costs
4.681.1138.3557.94
Loss (Gain) From Sale of Investments
-12.18-13.1-14.13-7.26
Provision & Write-off of Bad Debts
2.68-11.251.15-
Other Operating Activities
21.556.691.289.85
Change in Accounts Receivable
-13.82241.61-7.1913.37
Change in Inventory
-32.85-44.83-39.03-48.91
Change in Accounts Payable
-15.95-93.99-18.82-20.13
Change in Other Net Operating Assets
--0.760.73
Operating Cash Flow
-131.3980.938.6103.93
Operating Cash Flow Growth
-109.62%-62.86%-5.05%
Capital Expenditures
-38.48-54-168.18-386.39
Sale of Property, Plant & Equipment
0.27--0.05
Investment in Securities
188.98-145280.87-615
Other Investing Activities
-4.1811.3-4.95
Investing Cash Flow
146.59-187.71112.7-996.39
Short-Term Debt Issued
74.66652229.61
Total Debt Issued
74.66652229.61
Short-Term Debt Repaid
-91-44-20-515.96
Total Debt Repaid
-91-44-20-515.96
Net Debt Issued (Repaid)
-16.42232-286.35
Issuance of Common Stock
---1,150
Common Dividends Paid
-1.63-17.6-45.25-
Other Financing Activities
--1.88--22.98
Financing Cash Flow
-18.032.52-13.25841.14
Foreign Exchange Rate Adjustments
--0-
Net Cash Flow
-2.82-104.29138.04-51.33
Free Cash Flow
-169.8626.9-129.58-282.46
Free Cash Flow Margin
-210.22%19.99%-40.69%-72.01%
Free Cash Flow Per Share
-1.380.22-1.06-2.69
Cash Interest Paid
-1.88-9.85
Cash Income Tax Paid
5.017.2720.6243.48
Levered Free Cash Flow
-123.8393.07-80.61-297.59
Unlevered Free Cash Flow
-122.8394.26-79.81-291.44
Change in Working Capital
-85.0987.2-60.5-69.59
Source: S&P Global Market Intelligence. Standard template. Financial Sources.